Xiaowei G, Jaime V, Siyuan Z,et al. Molecular subtypes of glioblastoma are relevant to lower grade glioma[J]. PLoS ONE,2014, 9(3): 91216.
[2]
Santosh V,Arimappamagan A,Sree- Kanthreddy P,et al. Grade-specific expression of insulin-like growth factor-binding proteins-2,-3,and-5 in astrocytomas:IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma[J].Cancer Epidemiol Biomarkers prev,2010,19(6):1399-1408.
[3]
Malaguarnera R,Belfiore A.The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells[J].Front Endocrinol(Lausanne),2014,4(5):10.
[4]
Livingstone C. IGF2 and cancer[J]. Endocr Relat Cancer,2013, 20(6): 321-339.
Corcoran RB, Bachar Raveh T, Barakat MT, et al. Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice[J]. Cancer Res, 2008,68(21):8788-8795.
[7]
Suvasini R, Shruti B, Thota B,et al.Insulin growth factor-2 binding protein 3(IGF2BP3)is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase(PI3K/MAPK)pathways by modulating IGF-2[J]. J Biol Chem, 2011,286(29):2582-2589.
[8]
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system[J]. Acta Neuropathol,2007,114: 97？109.
Iker López-Calderero,Elizabeth Sánchez Chávez,Rocío García-Carbonero.The insulin-like growth factor pathway as a target for cancer therapy[J]. Clin Transl Oncol,2010,12:326-338.
[11]
Jennifer W,Andrew XZ.Targeting insulin-like growth factor axis in hepatocellular carcinoma[J]. Journal of Hematology & Oncology,2011, 4:30.
